Research ArticleHEALTH AND MEDICINE

Hybrid nanocarriers incorporating mechanistically distinct drugs for lymphatic CD4+ T cell activation and HIV-1 latency reversal

See allHide authors and affiliations

Science Advances  27 Mar 2019:
Vol. 5, no. 3, eaav6322
DOI: 10.1126/sciadv.aav6322
PDF Container

Stay Connected to Science Advances

Navigate This Article